Medincell: Notice of the 2025 Annual General Meeting Published

About this update from Medincell Sa

[{"type":"text","content":"MONTPELLIER, France, August 04, 2025--(BUSINESS WIRE)--Regulatory News:","length":71,"tagName":"p"},{"type":"text","content":"Medincell's (Paris:MEDCL) combined annual general meeting (ordinary and extraordinary) will be held on September 11, 2025, at 6pm at the Company's headquarters.","length":168,"tagName":"p"},{"type":"text","content":"The notice was published in the "BALO" (French):https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2025/0804/202508042503963.pdf","length":150,"tagName":"p"},{"type":"text","content":"The resolutions proposed for voting at the General Assembly include:","length":68,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Approval of the parent company and consolidated financial statements for the 2024-2025 fiscal year and allocation of the result;","length":128,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Election of new independent board members, seasoned professionals in the pharmaceutical field: Ms. Sharon Mates, Mr. Charles Kunsch, and Mr. Pascal Touchon;","length":156,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Approval of existing related-party agreements;","length":46,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Approval of executive compensation elements, including the budget allocated to Board of Directors’ remuneration, which has been revised this year to reflect:- The transition from a governance structure based on a Supervisory Board and Management Board to a Board of Directors, resulting in a significant increase in workload and responsibilities for its members,- The expansion of the Board (with the addition of two seats and one non-voting observer position),- The creation of new specialized committees requiring greater involvement from directors;","length":554,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Approval of executive compensation policies;","length":44,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Delegations granted to the Board of Directors to carry out, if necessary, capital increases or reductions, share cancellations, or issuance of securities granting access to capital.","length":181,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":1109,"olType":false},{"type":"text","content":"The procedures for parti...

More updates from Medincell Sa